Related Experiment Videos
Data mining technologies for blood glucose and diabetes management.
Riccardo Bellazzi1, Ameen Abu-Hanna
1Dipartimento di Informatica e Sistemistica, Università di Pavia, Pavia, Italy. riccardo.bellazzi@unipv.it
Journal of Diabetes Science and Technology
|February 11, 2010
Summary
Data mining uncovers patterns in blood glucose data for diabetes management and intensive care. This approach aids physicians and researchers in interpreting complex patient information for better health outcomes.
Area of Science:
- Biomedical Informatics
- Data Science
- Health Informatics
Background:
- Diabetes mellitus management generates vast patient data from electronic health records and monitoring systems.
- Interpreting large datasets of blood glucose readings is challenging for clinicians and researchers.
- Data mining offers a powerful approach to analyze complex biomedical data.
Purpose of the Study:
- To explore data mining applications in analyzing blood glucose and diabetes mellitus data.
- To illustrate the utility of data mining in two specific clinical contexts.
- To highlight the potential of data mining for researchers and practitioners.
Main Methods:
- Application of data mining techniques for pattern discovery in large datasets.
- Analysis of blood glucose home monitoring data from diabetes mellitus patients.
- Analysis of blood glucose monitoring data from intensive care unit patients.
Main Results:
- Data mining effectively identifies patterns in blood glucose monitoring data.
- Demonstrated utility in analyzing both home-based and intensive care unit patient data.
- Potential for improved clinical decision-making and patient management.
Conclusions:
- Data mining is highly applicable to diabetes mellitus data analysis.
- The approach is valuable for interpreting complex blood glucose trends in various clinical settings.
- Data mining enhances the understanding of patient data for improved healthcare outcomes.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...